1. Home
  2. GORO vs CCCC Comparison

GORO vs CCCC Comparison

Compare GORO & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gold Resource Corporation

GORO

Gold Resource Corporation

HOLD

Current Price

$1.60

Market Cap

194.1M

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.04

Market Cap

207.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GORO
CCCC
Founded
1998
2015
Country
United States
United States
Employees
N/A
110
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
194.1M
207.4M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
GORO
CCCC
Price
$1.60
$2.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$1.75
$7.25
AVG Volume (30 Days)
11.7M
1.5M
Earning Date
11-04-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$61,430,000.00
$30,108,000.00
Revenue This Year
$8.76
N/A
Revenue Next Year
$85.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.29
$1.09
52 Week High
$1.87
$3.84

Technical Indicators

Market Signals
Indicator
GORO
CCCC
Relative Strength Index (RSI) 65.74 42.37
Support Level $0.95 $2.07
Resistance Level $1.87 $2.23
Average True Range (ATR) 0.21 0.13
MACD 0.06 -0.00
Stochastic Oscillator 71.37 5.32

Price Performance

Historical Comparison
GORO
CCCC

About GORO Gold Resource Corporation

Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: